PTPN1 and obesity due to melanocortin 4 receptor deficiency: Though significant progress has been made in understanding the molecular mechanisms of PTP1B regulation in metabolic processes that affect diabetes, obesity and the heart, tissue-specific targeting and selective potency with existing PTP1B inhibitors remains challenging.